Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HVIVO PLC Director's Dealing 2016

Nov 2, 2016

7697_dirs_2016-11-02_0bab5624-dac3-4f0a-82d3-8650ec5eb1eb.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0838O

Venn Life Sciences Holdings PLC

02 November 2016

Venn Life Sciences Holdings Plc

("Venn Life Sciences" or the "Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Allan Wood
2 Reason for the notification
a) Position/status Chairman (PDMR)
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)

b)
Name

LEI code
Venn Life Science Holdings PLC

Pending
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of nominal value of 0.1 pence each
Identification code ISIN GB00B9275X97
b) Nature of the transaction Acquisition of ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
21.50p per share 65,000
21.73p per share 165,000
d) Aggregated information
- Aggregated volume 230,000
- Price 21.67 pence per share
e) Date of the transaction 31 October 2016
f) Place of the transaction London Stock Exchange AIM market
Venn Life Sciences Holdings Plc www.vennlifesciences.com
Tony Richardson, Chief Executive Officer Tel: +353 154 99 341
Davy (Nominated Adviser, ESM Adviser and Joint Broker)
Fergal Meegan / Matthew de Vere White (Corporate Finance) Tel: +353 1 679 6363
Paul Burke (Corporate Broking)
Hybridan LLP (Co-Broker)
Claire Louise Noyce Tel: +44(0)20 3764 2341
Walbrook PR Ltd Tel: +44(0)20 7933 8787 or [email protected]
Paul McManus Mob: +44(0) 7980 541 893
Lianne Cawthorne Mob: +44(0) 7854 391 303

About Venn Life Sciences: Venn Life Sciences is a Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn also has an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLIFIDLLLFIIR